CRT-100.33 A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) in Brazil and Japan: Synergy Stent with Prasugrel Monotherapy Without Aspirin
Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Patrick W. Serruys(Erasmus MC), Takayuki Okamura(Yamaguchi University), Nozomi Kotoku(St. Marianna University School of Medicine), Yosuke Miyazaki(Yamaguchi University), Shinichiro Masuda(Iwate Medical University), Yukio Ozaki(Kyushu University), Norihiro Kogame(Amsterdam UMC Location University of Amsterdam), Masato Nakamura(Toho University), Takashi Muramatsu(Tokyo Dental College), Pedro A. Lemos(Johns Hopkins University), Kai Ninomiya(Ollscoil na Gaillimhe – University of Galway), Gaku Nakazawa(Kindai University), Shigetaka Kageyama(Ollscoil na Gaillimhe – University of Galway), Ken Kozuma(Teikyo University Hospital), Kuniaki Takahashi(University of Amsterdam), Hideyuki Kawashima(Teikyo University), Taku Asano(St. Luke's International Hospital), Yuki Ishibashi(Erasmus University Rotterdam), Yuki Katagiri(University of Amsterdam), Shimpei Nakatani(Erasmus MC), Hiroki Tateishi(Erasmus University Rotterdam), Yoshihiro Morino(Iwate Medical University), Kengo Tanabe(Mitsui Memorial Hospital), Patrícia O. Guimarães(Universidade de São Paulo)
Cited by 1
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k